These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Gadolinium and neomycin block voltage-sensitive Ca2+ channels without interfering with the Na(+)-Ca2+ antiporter in brain nerve endings.
    Author: Canzoniero LM, Taglialatela M, Di Renzo G, Annunziato L.
    Journal: Eur J Pharmacol; 1993 Apr 15; 245(2):97-103. PubMed ID: 8491259.
    Abstract:
    The rare earth lanthanide gadolinium (Gd3+), in concentrations ranging from 1 to 100 microM, reduced the elevation of intracellular Ca2+ concentration [Ca2+]i, monitored by means of the fluorescent probe fura-2. It also decreased the influx of 45Ca2+ through voltage sensitive calcium channels (VSCC), induced by 55 mM K+ in Percoll-purified brain synaptosomes. By contrast, Gd3+ (0.1-30 microM) did not interfere with Na(+)-dependent 45Ca2+ uptake, a process which expresses Na(+)-Ca2+ exchange activity. The aminoglycoside neomycin displayed a similar pattern of activity although at higher concentrations (300-1000 microM). At the same range of concentrations (100 and 300 microM), the phenylalkylamine, verapamil, blocked both Ca2+ entry through VSCC and Ca2+ influx through the Na(+)-Ca2+ exchanger. Finally, nimodipine failed to prevent 45Ca2+ influx in either case, and fura-2 monitored [Ca2+]i elevation induced by high K(+)- or Na(+)-dependent 45Ca2+ uptake. Collectively, the data obtained in the present study indicate that Gd3+ and neomycin can be considered to be valid pharmacological tools for selective blocking of VSCC in cerebral nerve terminals, without any concomitant interference with the Na(+)-Ca2+ antiporter, whereas the inhibitory action of verapamil does not discriminate between Ca2+ entry through VSCC or the antiporter.
    [Abstract] [Full Text] [Related] [New Search]